Trends in the commercial development of antibody therapeutics: The early-stage clinical pipeline
1:09:35
Antibodies to watch in 2024
25:33
Trends in the early-stage clinical development of antibody therapeutics
1:08:53
Latest Advancements in Antibody Engineering – Bispecifics, Diagnostic Controls, and More
1:09:57
Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/2 Targeted Myeloid Suppression
1:01:02
Accelerating Antibody Drug Discovery Through Computational Modeling
33:02
Enabling faster therapeutic antibody discovery through an integrated AI/ML-wet lab platform
54:39
Innovative Technologies for Antibody Discovery, Transforming Hit Generation & Lead Characterization
46:00